ITI Treatment Guide Volume 14 - Home - ITI,ITI Treatment Guide Volume 14,ASCO 2022: A phase I open-label dose escalation of YH003 (CD40 mAb) in combination with toripalimab (PD-1 mAb) in patients with advanced solid tumors - Biocytogen,CN103265489A - ent-(14S)-3-甲氧基-17-甲基吗喃的制备方法- Google Patents,Frontiers | TIGIT as a Promising Therapeutic Target in Autoimmune Diseases,